Same-day 2-L PEG-citrate-simethicone plus bisacodyl vs split 4-L PEG: Bowel cleansing for late-morning colonoscopy
被引:37
|
作者:
de Leone, Annalisa
论文数: 0引用数: 0
h-index: 0
机构:
European Inst Oncol, Div Endoscopy, Via Ripamonti 435, I-20141 Milan, ItalyEuropean Inst Oncol, Div Endoscopy, Via Ripamonti 435, I-20141 Milan, Italy
de Leone, Annalisa
[1
]
Tamayo, Darina
论文数: 0引用数: 0
h-index: 0
机构:
European Inst Oncol, Div Endoscopy, Via Ripamonti 435, I-20141 Milan, ItalyEuropean Inst Oncol, Div Endoscopy, Via Ripamonti 435, I-20141 Milan, Italy
Tamayo, Darina
[1
]
论文数: 引用数:
h-index:
机构:
Fiori, Giancarla
[1
]
Ravizza, Davide
论文数: 0引用数: 0
h-index: 0
机构:
European Inst Oncol, Div Endoscopy, Via Ripamonti 435, I-20141 Milan, ItalyEuropean Inst Oncol, Div Endoscopy, Via Ripamonti 435, I-20141 Milan, Italy
Ravizza, Davide
[1
]
论文数: 引用数:
h-index:
机构:
Trovato, Cristina
[1
]
De Roberto, Giuseppe
论文数: 0引用数: 0
h-index: 0
机构:
European Inst Oncol, Div Endoscopy, Via Ripamonti 435, I-20141 Milan, ItalyEuropean Inst Oncol, Div Endoscopy, Via Ripamonti 435, I-20141 Milan, Italy
De Roberto, Giuseppe
[1
]
Fazzini, Linda
论文数: 0引用数: 0
h-index: 0
机构:
Gastroenterol & Endoscopy Dept, I-20159 Milan, ItalyEuropean Inst Oncol, Div Endoscopy, Via Ripamonti 435, I-20141 Milan, Italy
Fazzini, Linda
[2
]
Dal Fante, Marco
论文数: 0引用数: 0
h-index: 0
机构:
Gastroenterol & Endoscopy Dept, I-20159 Milan, ItalyEuropean Inst Oncol, Div Endoscopy, Via Ripamonti 435, I-20141 Milan, Italy
Dal Fante, Marco
[2
]
Crosta, Cristiano
论文数: 0引用数: 0
h-index: 0
机构:
European Inst Oncol, Div Endoscopy, Via Ripamonti 435, I-20141 Milan, ItalyEuropean Inst Oncol, Div Endoscopy, Via Ripamonti 435, I-20141 Milan, Italy
Crosta, Cristiano
[1
]
机构:
[1] European Inst Oncol, Div Endoscopy, Via Ripamonti 435, I-20141 Milan, Italy
AIM: To evaluate the efficacy, tolerability, acceptability and feasibility of bisacodyl plus low volume polyethyleneglycol- citrate-simeticone (2-L PEG-CS) taken the same day as compared with conventional split-dose 4-L PEG for late morning colonoscopy. METHODS: Randomised, observer-blind, parallel group, comparative trial carried out in 2 centres. Out patients of both sexes, aged between 18 and 85 years, undergoing colonoscopy for diagnostic investigation, colorectal cancer screening or follow-up were eligible. The PEG-CS group received 3 bisacodyl tablets (4 tablets for patients with constipation) at bedtime and 2-L PEG-CS in the morning starting 5 h before colonoscopy. The control group received a conventional 4-L PEG formulation given as split regimen; the morning dose was taken with the same schedule of the low volume preparation. The Ottawa Bowel Preparation Scale (OBPS) score was used as the main outcome measure. RESULTS: A total of 164 subjects were enrolled and 154 completed the study; 78 in the PEG-CS group and 76 in the split 4-L PEG group. The two groups were comparable at baseline. The OBPS score in the PEG-CS group (3.09 `+/- 2.40) and in the PEG group (2.39 +/- 2.55) were equivalent (difference + 0.70; 95% CI: -0.09-1.48). This was confirmed by the rate of successful bowel cleansing in the PEG-CS group (89.7%) and in the PEG group (92.1%) (difference -2.4%; 95% CI: -11.406.70). PEG-CS was superior in terms of mucosa visibility compared to PEG (85.7% vs 72.4%, P = 0.042). There were no significant differences in caecum intubation rate, time to reach the caecum and withdrawal time between the two groups. The adenoma detection rate was similar (PEG-CS 43.6% vs PEG 44.7%). No serious adverse events occurred. No difference was found in tolerability of the bowel preparations. Compliance was equal in both groups: more than 90% of subjects drunk the whole solution. Willingness to repeat the same bowel preparations was about 90% for both regimes. CONCLUSION: Same-day PEG-CS is feasible, effective as split-dose 4-L PEG for late morning colonoscopy and does not interfere with work and daily activities the day before colonoscopy. (C) 2013 Baishideng. All rights reserved.